Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background: Differences in free beta HCG and PAPP-A values, which are among the biochemical parameters in the double screening test, is frequently used for pregnancy follow-up, allow aneuploidy and triploidy risk to be determined. In recent studies, it’s suggested that the modified hemogram indices have gained importance as a marker in the prognosis of diseases. Objective: In this study, we aimed to determine the hematological parameters, which are routinely applied in the first trimester of pregnancy, have any value in predicting the risk increase in the double screening test and in early diagnosis. Method: Pregnant women who conceived spontaneously and had double screening tests were included in the study. CBC results that were studied together with the first trimester screening test were reported. The patients were divided into two groups according to the results of the screening test as the combined risk ratio. Results: The mean age was found to be significantly higher in the high-risk group than in the low-risk group. Monocyte, % M and WBC values were significantly lower in the high-risk group (0,483±0,140, 5,58±1,44 and 8,75±2,12 , respectively). There was no significant difference in NLR and PLR values compared between the groups. MPV values were lower and PAPP-A, PAPP-A MoM values were significantly lower in high-risk group compared to the low-risk group. Conclusion: The findings support low Monocyte, % M and WBC values as a potential marker for the identification of the high risk pregnancy in otherwise healthy pregnant women. The results indicate that CBC parametres commonly used in pregnancy can be used to predict the prognosis.
Background: Differences in free beta HCG and PAPP-A values, which are among the biochemical parameters in the double screening test, is frequently used for pregnancy follow-up, allow aneuploidy and triploidy risk to be determined. In recent studies, it’s suggested that the modified hemogram indices have gained importance as a marker in the prognosis of diseases. Objective: In this study, we aimed to determine the hematological parameters, which are routinely applied in the first trimester of pregnancy, have any value in predicting the risk increase in the double screening test and in early diagnosis. Method: Pregnant women who conceived spontaneously and had double screening tests were included in the study. CBC results that were studied together with the first trimester screening test were reported. The patients were divided into two groups according to the results of the screening test as the combined risk ratio. Results: The mean age was found to be significantly higher in the high-risk group than in the low-risk group. Monocyte, % M and WBC values were significantly lower in the high-risk group (0,483±0,140, 5,58±1,44 and 8,75±2,12 , respectively). There was no significant difference in NLR and PLR values compared between the groups. MPV values were lower and PAPP-A, PAPP-A MoM values were significantly lower in high-risk group compared to the low-risk group. Conclusion: The findings support low Monocyte, % M and WBC values as a potential marker for the identification of the high risk pregnancy in otherwise healthy pregnant women. The results indicate that CBC parametres commonly used in pregnancy can be used to predict the prognosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.